Cargando…

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants

It has been reported that multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) including Alpha, Beta, Gamma, and Delta can reduce neutralization by antibodies, resulting in vaccine breakthrough infections. Virus–antiserum neutralization assays are typicall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ye-Fan, Hu, Jing-Chu, Gong, Hua-Rui, Danchin, Antoine, Sun, Ren, Chu, Hin, Hung, Ivan Fan-Ngai, Yuen, Kwok Yung, To, Kelvin Kai-Wang, Zhang, Bao-Zhong, Yau, Thomas, Huang, Jian-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987580/ https://www.ncbi.nlm.nih.gov/pubmed/35401572 http://dx.doi.org/10.3389/fimmu.2022.861050

Ejemplares similares

Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients
por: Zhang, Bao-zhong, et al.
Publicado: (2020)

SARS-CoV-2 infects human neural progenitor cells and brain organoids
por: Zhang, Bao-Zhong, et al.
Publicado: (2020)

Early triple antiviral therapy for COVID-19 – Authors' reply
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2020)

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model
por: Chen, Yanxia, et al.
Publicado: (2022)

Co-stimulation With TLR7 Agonist Imiquimod and Inactivated Influenza Virus Particles Promotes Mouse B Cell Activation, Differentiation, and Accelerated Antigen Specific Antibody Production
por: Li, Can, et al.
Publicado: (2018)

Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production
por: Li, Can, et al.
Publicado: (2022)

Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management
por: To, Kelvin Kai-Wang, et al.
Publicado: (2010)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19
por: Lam, Athene Hoi-Ying, et al.
Publicado: (2021)

Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant
por: Zhang, Ruiqi, et al.
Publicado: (2021)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice
por: Ye, Zi-Wei, et al.
Publicado: (2017)

Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19)
por: Cheng, Vincent Chi-Chung, et al.
Publicado: (2020)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines
por: Zhang, Ruiqi, et al.
Publicado: (2022)

A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters
por: Zhang, Bao-Zhong, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants expand species tropism to murines
por: Shuai, Huiping, et al.
Publicado: (2021)

Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong
por: To, Kelvin Kai-Wang, et al.
Publicado: (2014)

Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccines
por: Zhang, Xiaojuan, et al.
Publicado: (2023)

Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
por: Khong, Ka-Wa, et al.
Publicado: (2022)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 Patients
por: Mo, Yufei, et al.
Publicado: (2022)

Neurosensory Rehabilitation and Olfactory Network Recovery in Covid-19-related Olfactory Dysfunction
por: Chung, Tom Wai-Hin, et al.
Publicado: (2021)

SARS-CoV-2 exploits host DGAT and ADRP for efficient replication
por: Yuan, Shuofeng, et al.
Publicado: (2021)

Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study
por: Ho-Yan Fong, Carol, et al.
Publicado: (2023)

Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice
por: Zhang, Bao-Zhong, et al.
Publicado: (2022)

Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
por: Simayi, Aidibai, et al.
Publicado: (2023)

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
por: Chan, Jasper Fuk-Woo, et al.
Publicado: (2020)

Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
por: To, Kelvin Kai-Wang, et al.
Publicado: (2021)

Viral Infections, an Overview with a Focus on Prevention of Transmission
por: Cheng, Vincent Chi-Chung, et al.
Publicado: (2017)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction
por: Lau, Siu-Ying, et al.
Publicado: (2020)

Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples
por: Chan, Kwok-Hung, et al.
Publicado: (2021)

Breakthrough of glycobiology in the 21st century
por: Mahara, Gehendra, et al.
Publicado: (2023)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model
por: Li, Can, et al.
Publicado: (2021)

Human Nasal Organoids Model SARS-CoV-2 Upper Respiratory Infection and Recapitulate the Differential Infectivity of Emerging Variants
por: Chiu, Man Chun, et al.
Publicado: (2022)

PExFInS: An Integrative Post-GWAS Explorer for Functional Indels and SNPs
por: Cheng, Zhongshan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8fqu557p69d1qpksj6uff21l44